References
- 1. J. He, X. Wang, X. Zhao, Y. J. Liang, H. He and L. Fu, Synthesis and antitumor activity of novel quinazoline derivatives containing thiosemicarbazide moiety, Eur. J. Med. Chem.54 (2012) 925–930; https://doi.org/10.1016/j.ejmech.2012.06.00310.1016/j.ejmech.2012.06.003
- 2. C. D. Haffner, J. D. Becherer, E. E. Boros, R. Cadilla, T. Carpenter, D. Cowan, D. N. Deaton, Y. Guo, W. Harrington, B. R. Henke, M. R. Jeune, I. Kaldor, N. Milliken and K. G. Petrov, Discovery, synthesis, and biological evaluation of thiazoloquin(az)olin(on)es as potent CD38 inhibitors, J. Med. Chem.58 (2015) 3548–3571; https://doi.org/10.1021/jm502009h10.1021/jm502009h
- 3. R. V. Sheorey, A. Thangathiruppathy and V. Alagarsamy, Synthesis and pharmacological evaluation of 3-propyl-2-substitutedamino-3h-quinazolin-4-ones as analgesic and anti-inflammatory agents, J. Heterocycl. Chem.53 (2016) 1371–1377; https://doi.org/10.1002/jhet.197310.1002/jhet.1973
- 4. M. Hrast, K. Rožman, M. Jukič, D. Patin, S. Gobec and M. Sova, Synthesis and structure-activity relationship study of novel quinazolinone-based inhibitors of MurA, Bioorg. Med. Chem.27 (2017) 3529–3533; https://doi.org/10.1016/j.bmcl.2017.05.06410.1016/j.bmcl.2017.05.064
- 5. M. Sarfraz, N. Sultana, U. Rashid, M. S. Akram, A. Sadiq and M. I. Tariq, Synthesis, biological evaluation and docking studies of 2,3-dihydroquinazolin-4(1H)-one derivatives as inhibitors of cholinesterases, Bioorg. Chem.70 (2017) 237–244; https://doi.org/10.1016/j.bioorg.2017.01.00410.1016/j.bioorg.2017.01.004
- 6. I. K. Kacker and S. H. Zaheer, Reactions of substituted 3:4-dihydro-4-oxoquinazolines with Grignard reagents, J. Chem. Soc. (1956) 415–418; https://doi.org/10.1039/JR956000041510.1039/jr9560000415
- 7. J. F. Wolfe, T. L. Rathman, M. C. Sleevi, J. A. Campbell and T. D. Greenwood, Synthesis and anticonvulsant activity of some new 2-substituted 3-aryl-4(3H)-quinazolinones, J. Med. Chem.33 (1990) 161–166; https://doi.org/10.1021/jm00163a02710.1021/jm00163a027
- 8. J. Bergman and A. Brynolf, Synthesis of chrysogine, a metabolite of Penicillium chrysogenum and some related 2-substituted 4-(3H)-quinazolinones, Tetrahedron46 (1990) 1295–1310; https://doi.org/10.1016/s0040-4020(01)86694-110.1016/S0040-4020(01)86694-1
- 9. S. Eguchi, T. Suzuki, T. Okawa, Y. Matsushita, E. Yashima and Y. Okamoto, Synthesis of optically active vasicinone based on intramolecular aza-Wittig reaction and asymmetric oxidation, J. Org. Chem.61 (1996) 7316–7319; https://doi.org/10.1021/jo960928310.1021/jo960928311667656
- 10. K. Smith, G. A. El-Hiti and M. F. Abdel-Megeed, Regioselective lithiation of chiral 3-acylamino-2-alkylquinazolin-4(3H)-ones: Application in synthesis, Synthesis (issue 13) (2004) 2121–2130; https://doi.org/10.1055/s-2004-82916910.1055/s-2004-829169
- 11. C. D. Dago, C. N. Ambeu, W.-K. Coulibaly, Y.-A. Beekro, J. Mamyrbeekova, A. Defontaine, B. Baratte, S. Bach, S. Ruchaud, R. Le Gueevel, M. Ravache, A. Corlu and J.-P. Bazureau, Synthetic development of new 3-(4-arylmethylamino)butyl-5-arylidene-rhodanines under microwave irradiation and their effects on tumor cell lines and against protein kinases, Molecules20 (2015) 12412–12435; https://doi.org/10.3390/molecules20071241210.3390/molecules200712412633231826184130
- 12. M. A. El-Hashash, T. M. Abdel-Rahman and Y. A. El-Badry, Synthesis and behavior of 2-carboxyvinyl-6,8-dibromo-4H-3,1-benzoxazin-4-one towards nitrogen, carbon and sulphur nucleophiles, Indian J. Chem.45B (2006) 1470–1477; https://doi.org/10.1002/chin.20064103010.1002/chin.200641030
- 13. H. Chai, J. Li, L. Yang, H. Lu, Z. Qi and D. Shi, Copper-catalyzed tandem N-arylation/condensation: synthesis of quinazolin-4(3H)-ones from 2-halobenzonitriles and amides, RSC Adv.4 (2014) 44811–44814; https://doi.org/10.1039/c4ra08031a10.1039/C4RA08031A
- 14. G. A. Obafemi, O. A. Fadare, J. P. Jasinski, S. P. Millikan, E. M. Obuotor, E. O. Iwalewa, S. O. Famuyiwa, K. Sanusi, Y. Yilmaz and U. Ceylan, Microwave-assisted synthesis, structural characterization, DFT studies, antibacterial and antioxidant activity of 2-methyl-4-oxo-1,2,3,4-tetrahydroquinazoline-2-carboxylic acid, J. Mol. Str.1155 (2018) 610–622; https://doi.org/10.1016/j.molstruc.2017.11.01810.1016/j.molstruc.2017.11.018
- 15. M. A. El-Hashash and Y. A. El-Badry, Synthesis of a novel series of 2,3-disubstituted quinazolin-4(3H)-ones as a product of a nucleophilic attack at C(2) of the corresponding 4H-3,1-benzoxazin-4-one, Helv. Chim. Acta94 (2011) 389–396; https://doi.org/10.1002/hlca.20100023010.1002/hlca.201000230
- 16. D. H. Hieu, D. T. Anh, N. M. Tuan, P-T. Hai, L.-T.-T. Huong, J. Kim, J. S. Kang, T. K. Vu, P. T. P. Dung, S.-B. Han, N.-H. Nam and N.-D. Hoa, Design, synthesis and evaluation of novel N-hydroxybenzamides/N-hydroxypropenamides incorporating quinazolin-4(3H)-ones as histone deacetylase in hibitors and antitumor agents, Bioorg. Chem.76 (2018) 258–267; https://doi.org/10.1016/j.bioorg.2017.12.00710.1016/j.bioorg.2017.12.00729223029
- 17. Y. A. El-Badry, N. A. Anter and H. S. El-Sheshtawy, Synthesis and evaluation of new polysubstituted quinazoline derivatives as potential antimicrobial agents, Pharma Chem.4 (2012) 1361–1370.
- 18. C. Valgas, S. De Souza, E. Smaenia and A. Smaenia, Screening methods to determine antibacterial activity of natural products, Braz. J. Microbiol.38 (2007) 369–380; https://doi.org/10.1590/s1517-8382200700020003410.1590/S1517-83822007000200034
- 19. A. Monks, D. Scudiero, P. Skehan, R. Shoemaker, K. Paull, D. Vistica, C. Hose, J. Langley, P. Cronise, A. Vaigro-Wolff, M. Gray-Goodrich, H. Campbell, J. Mayo and M. Boyd, Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines, J. Natl. Cancer Inst.83 (1991) 757–766; https://doi.org/10.1093/jnci/83.11.75710.1093/jnci/83.11.7572041050
- 20. M. R. Boyd and K. D. Paull, Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen, Drug Develop. Res.34 (1995) 91–109; https://doi.org/10.1002/ddr.43034020310.1002/ddr.430340203
- 21. R. H. Shoemaker, The NCI60 human tumour cell line anticancer drug screen, Nat. Rev. Cancer6 (2006) 813–823; https://doi.org/10.1038/nrc195110.1038/nrc195116990858
- 22. S. Fozooni and S. Firoozi, Microwave-assisted synthesis of new quinazolinone and (dihydroquinazolinylphenyl)oxazolone derivatives, Chem. Heterocycl. Compd.51 (2015) 340–345; https://doi.org/10.1007/s10593-015-1705-610.1007/s10593-015-1705-6
- 23. I. Nouira, I. K. Kostakis, C. Dubouilh and E. Chosson, Decomposition of formamide assisted by microwaves, a tool for synthesis of nitrogen-containing heterocycles, Tetrahedron Lett.49 (2008) 7033–7036; https://doi.org/10.1016/j.tetlet.2008.09.13510.1016/j.tetlet.2008.09.135
- 24. A. Loupy, A. Petit and D. Bogdal, Microwaves and Phase-Transfer Catalysis, in Microwaves in Organic Synthesis (Ed. A. Loupy), 2nd ed., Wiley-VCH Verlag GmbH & KgaA, Weinheim 2006, pp. 278–280.10.1002/9783527619559.ch6
- 25. A. Loupy, A. Petit, J. Hamelin, F. Texier-Boullet, P. Jacquault and D. Mathé, New solvent-free organic synthesis using focused microwaves, Synthesis (1998) 1213–1234; https://doi.org/10.1055/s-1998-608310.1055/s-1998-6083
- 26. Z.-Z. Huang and L.-S. Zu, Rapid N-alkylation of benzoxazinones and benzothiazinones under microwave irradiation, Org. Prep. Proc. Int.28 (1996) 121–123; https://doi.org/10.1080/0030494960935591710.1080/00304949609355917
- 27. M. Gupta and B. P. Wakhloo, Tetrabutylammonium bromide mediated Knoevenagel condensation in water: Synthesis of cinnamic acids, ARKIVOC15 (2007) 94–98; https://doi.org/10.3998/ark.5550190.0008.11010.3998/ark.5550190.0008.110
- 28. V. Blokzijl and J. B. F. N. Engberts, Hydrophobic effects. Opinions and facts, Angew. Chem. Int. Edit.32 (1993) 1545–1579.10.1002/anie.199315451
- 29. F. Bigi, M. L. Conforti, R. Maggi, A. Piccinno and G. Sartori, Clean synthesis in water: uncatalyzed preparation of ylidenemalononitriles, Green Chem.2 (2000) 101–103; https://doi.org/10.1039/b001246g10.1039/b001246g
- 30. M. C. Alley, D. Scudiero, P. A. Monks, M. L. Hursey and M. J. Czerwinski, Feasibility of drug screening with panels of human tumor cell lines using a micro-culture tetrazolium assay, Cancer Res.48 (1988) 589–601.